|Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause|
JE Rossouw, RL Prentice, JAE Manson, LL Wu, D Barad, VM Barnabei, ...
Jama 297 (13), 1465-1477, 2007
|Calcium plus vitamin D supplementation and the risk of fractures|
RD Jackson, AZ LaCroix, M Gass, RB Wallace, J Robbins, CE Lewis, ...
New England Journal of Medicine 354 (7), 669-683, 2006
|Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial|
GL Anderson, HL Judd, AM Kaunitz, DH Barad, SAA Beresford, ...
Jama 290 (13), 1739-1748, 2003
|Semen analyses in 1,283 men from the United States over a 25-year period: no decline in quality|
H Fisch, ET Goluboff, JH Olson, J Feldshuh, SJ Broder, DH Barad
Fertility and sterility 65 (5), 1009-1014, 1996
|Gender as risk factor for autoimmune diseases|
N Gleicher, DH Barad
Journal of autoimmunity 28 (1), 1-6, 2007
|Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks|
K Oktay, JY Kim, D Barad, SN Babayev
Journal of Clinical Oncology 28 (2), 240, 2010
|Fracture risk among breast cancer survivors: results from the Women’s Health Initiative Observational Study|
Z Chen, M Maricic, TL Bassford, M Pettinger, C Ritenbaugh, AM Lopez, ...
Archives of Internal Medicine 165 (5), 552-558, 2005
|Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF|
D Barad, N Gleicher
Human Reproduction 21 (11), 2845-2849, 2006
|Androgens regulate ovarian follicular development by increasing follicle stimulating hormone receptor and microRNA-125b expression|
A Sen, H Prizant, A Light, A Biswas, E Hayes, HJ Lee, D Barad, ...
Proceedings of the National Academy of Sciences 111 (8), 3008-3013, 2014
|Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function|
D Barad, H Brill, N Gleicher
Journal of assisted reproduction and genetics 24 (12), 629-634, 2007
|Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR)|
N Gleicher, DH Barad
Reproductive Biology and Endocrinology 9 (1), 1-12, 2011
|Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial|
RL Prentice, R Langer, ML Stefanick, BV Howard, M Pettinger, ...
American journal of epidemiology 162 (5), 404-414, 2005
|Successful treatment of unresponsive thin endometrium|
N Gleicher, A Vidali, DH Barad
Fertility and sterility 95 (6), 2123. e13-2123. e17, 2011
|The annual ovarian cycle of Chrysemys picta: correlated changes in plasma steroids and parameters of vitellogenesis|
IP Callard, V Lance, AR Salhanick, D Barad
General and Comparative Endocrinology 35 (3), 245-257, 1978
|The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of participants.|
ML Stefanick, BB Cochrane, J Hsia, DH Barad, JH Liu, SR Johnson
Annals of epidemiology 13 (9 Suppl), S78-86, 2003
|Symptom experience after discontinuing use of estrogen plus progestin|
JK Ockene, DH Barad, BB Cochrane, JC Larson, M Gass, ...
Jama 294 (2), 183-193, 2005
|Expression of colony-stimulating factor-1 in the human uterus and placenta|
E Daiter, S Pampfer, YG Yeung, D Barad, ER Stanley, JW Pollard
The Journal of Clinical Endocrinology & Metabolism 74 (4), 850-858, 1992
|Defining ovarian reserve to better understand ovarian aging|
N Gleicher, A Weghofer, DH Barad
Reproductive biology and endocrinology 9 (1), 1-11, 2011
|Increased oocyte production after treatment with dehydroepiandrosterone|
DH Barad, N Gleicher
Fertility and Sterility 84 (3), 756. e1-756. e3, 2005
|A pilot cohort study of granulocyte colony-stimulating factor in the treatment of unresponsive thin endometrium resistant to standard therapies|
N Gleicher, A Kim, T Michaeli, HJ Lee, A Shohat-Tal, E Lazzaroni, ...
Human Reproduction 28 (1), 172-177, 2013